Respiratory Syncytial Virus Infections Clinical Trials in Omaha, Nebraska
2 recruitingOmaha, Nebraska
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Respiratory Syncytial Virus Infections
GlaxoSmithKline184 enrolled37 locationsNCT07092865
Recruiting
Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Respiratory Syncytial Virus Infections
University of Alabama at Birmingham370 enrolled15 locationsNCT05026749